Youcare Pharmaceutical (SH:688658)2024-09-30 10:46Group 1: Company Overview - The company is named YK Pharmaceutical Group Co., Ltd. with stock code 688658 [1] - The investor relations activity involved multiple prominent funds and securities firms [2] Group 2: Product Development - The Ginkgo biloba extract injection is primarily used in departments such as internal medicine, cardiovascular, and endocrinology, with expected growth in usage in otolaryngology and geriatrics [2] - The hydroxyl safflower yellow A injection is currently in the NDA stage [2] - The company has established a platform for small nucleic acid drugs and mRNA vaccine development, enhancing its R&D capabilities across the entire chain from target selection to clinical trials [3] Group 3: Innovations and Patents - The company has achieved significant breakthroughs in nucleic acid drug delivery technology, obtaining 10 invention patents by the end of 2023 [3] - The first siRNA drug targeting PCSK9, YKYY015, has received a national invention patent and is undergoing international patent application [4] - Preclinical studies show that YKYY015 exhibits significant inhibition of the target gene PCSK9 with an IC50 value of less than 1 nM [4] Group 4: Marketing and Sales Strategy - The company has a mature marketing system and plans to optimize its sales channels and enhance collaboration with large pharmaceutical distribution companies [4] - Continuous academic promotion and professional training for sales personnel are part of the strategy to strengthen the marketing network [4] Group 5: Compliance and Communication - The company ensures compliance with legal regulations and maintains transparent communication with investors, adhering to its information disclosure management system [5]